Infectious Disease POC Diagnostics Market Size 2021 | Is Projected to Reach USD 3,371.1 Million with 17.4% CAGR by 2027

Pune, India, April 27, 2021 (GLOBE NEWSWIRE) -- The global infectious disease POC diagnostics market size  is projected to reach USD 3,371.1 million by the end of 2027. The presence of several large-scale companies in this sector will emerge in favor of market growth. According to a report published by Fortune Business Insights, titled “Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test, Molecular Diagnostics, and Others), By Disease (HIV, Hepatitis B Virus, Pneumonia/Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV), Influenza, Clostridium Difficile Infections (CDI), Hepatitis C Virus, Methicillin Resistant Staphylococcus Aureus (MRSA), Tuberculosis, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, Home & Self-Testing, Nursing Homes, and Others), and Regional Forecast, 2020-2027” the market was worth USD 1246.5 million and will exhibit a CAGR of 17.4% during the forecast period, 2020-2027.

Point of care (PoC) testing allows faster diagnosis of diseases at the patient site itself. The drawbacks of conventional diagnostic methods including time to test, inefficiency, and non-portability can be overcome through infectious disease PoC diagnosis. Recent technological advances have opened up a massive potential for the growth of the market in the past few years. The increasing popularity of this concept is consequential to the rapid technological advances. The increasing product demand has encouraged companies to invest higher upfront capital. The sector holds a huge potential for entry-level as well as mid-sized companies across the world. Additionally, increasing research activities will also emerge in favor of market growth in the forthcoming years.

Request a Sample Copy of the Research Report:

List of companies profiled in the report:

  • F. Hoffmann-La Roche Ltd (Basel, Switzerland)
  • Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
  • Abbott Laboratories (Illinois, U.S)
  • Quest Diagnostics Incorporated (New Jersey, United States)
  • BD (Franklin Lakes, U.S)
  • bioMérieux SA (Marcy l'Etoile, France)
  • Cardinal Health, Inc. (Ohio, U.S)
  • Mesa Biotech (California, U.S)
  • Cepheid (California, U.S)
  • Trinity Biotech (Bray, Ireland)
  • Quidel Corporation (San Diego, U.S.)
  • Bio-Rad Laboratories Inc. (California, U.S)
  • Other Players

Infectious Disease Point of Care Diagnostics Highlights of the Report:

  1. Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  2. Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
  3. Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  4. Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  5. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Industry Developments:

June 2020 - Cepheid announced launch of Xpert Xpress SARS-CoV-2/Flu/RSV a four in one combination test used for the detection of detection of SARS-CoV-2, Flu A, Flu B and RSV from a sample of single patient.

An Overview of the Impact of COVID-19 on this Market :

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.

For more information visit :

Covid-19 Pandemic to Create Massive Opportunities for Rapid Market Growth

The recent coronavirus outbreak has created a sense of panic and urgency across the world. The pandemic has had a drastic impact on several economies across the globe, with SMEs being affected the most. With only large-scale companies being able to sustain the drawbacks of the pandemic in a seamless manner, it is evident that these companies will look to adopt newer strategies to recover the losses in the past few months. The use of several PoC diagnostic test kits has risen dramatically in the past few months, given the ability of the product to generate results in a time span that is lesser than 30 mins. Having said that, major attention has been given to the SARS-Cov-2 infection and other diagnostic products have been kept on hold. As a result, the Covid-19 pandemic has brought mixed fortunes for companies in the infectious disease PoC diagnostics market.

Increasing Product Use during Covid-19 Pandemic will Emerge in Favor of Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years.  The massive investments in infectious disease PoC diagnostics have yielded a few exceptional products, enabling applications across diverse treatment procedures. The product has also been put to use in detecting symptoms of Covid-19 in the ongoing pandemic. Several large-scale companies are looking to maximize the use of the product during the pandemic and as a result, the investments in PoC diagnostics has gone up considerably in the past few months.

In May 2020, Quest Diagnostics announced that it has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its self-collection antibody test kits. The product is used for test kit for Covid-19 for patients looking to get tested from home. Increasing number of product innovations will have a huge impact on the growth of the overall market in the coming years.

Quick Buy -  Infectious Disease POC Diagnostics Market Research Report:

North America to Emerge Dominant; Growing Penetration of Advanced PoC Diagnostics will Emerge in Favor of Market Growth

The report analyzes the ongoing market trends across North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing adoption of advanced PoC diagnostics, especially in the United States, has contributed to the growth of the regional market.

The increasing Covid-19 cases has also given the platform for companies in the infectious disease PoC diagnostics sector. As of 2019, the market in North America was worth USD 457.2 million and this value is projected to rise at a considerable pace in the coming years. The market in Europe held the second largest share, following North America in the global market.

Have Any Query? Ask Our Experts:

Global Infectious Disease POC Diagnostics Market Segmentation :

By Technique

  • Lateral Flow Immunoassay (LFIA)
  • Agglutination Test
  • Flow-through test/Immunoconcentration Assay
  • Molecular Diagnostics
  • Others

By Disease

  • HIV
  • Hepatitis B Virus
  • Pneumonia/Streptococcus Associated Infections
  • Respiratory Syncytial Virus (RSV)
  • Influenza
  • Clostridium Difficile Infections (CDI)
  • Hepatitis C Virus
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Tuberculosis (TB)
  • Others

By End User

  • Hospital Bedside
  • Physician's Office Lab
  • Urgent Care & Retail Clinics
  • Home & Self-testing
  • Nursing Home
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table Of Content :

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Key Infectious Diseases, By Key Countries
    • New Product Launches
    • Key Industrial Developments (Mergers, Acquisitions, Partnerships, etc.)
    • Technological Advancements in Infectious Disease Point of Care (POC) Diagnostics
    • Impact of COVID-19 on Infectious Disease Point of Care (POC) Diagnostics Market
    • Overview of Initiatives for Infectious Disease Point of Care (POC) Diagnostics in Emerging Countries
    • Pricing Analysis of Various Infectious Disease Point of Care (POC) Diagnostics, By Key Companies
    • Analysis of Product Features of Key Infectious Disease Point of Care (POC) Diagnostics, By Key Companies
  • Global Infectious Disease Point-of-care (POC) Diagnostics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Technique
        • Lateral Flow Immunoassay (LFIA)
      • Agglutination Tests
      • Flow-through Tests / Immunoconcentration Assays
      • Molecular Diagnostics
      • Others
    • Market Analysis, Insights and Forecast By Disease
      •  Human Immunodeficiency Virus (HIV)
      •  Hepatitis B Virus (HBV)
      •  Pneumonia / Streptococcus Associated Infections
      •  Respiratory Syncytial Virus (RSV)
      •  Influenza
      •  Clostridium difficile infection (CDI)
      •  Hepatitis C Virus (HCV)
      •  Methicillin-Resistant Staphylococcus Aureus (MRSA)
      •  Tuberculosis (TB)
      •  Others
    • Market Analysis, Insights and Forecast By End User
      •  Hospital Bedside
      •  Physician's Office Lab
      •  Urgent Care & Retail Clinics
      •  Home & Self-Testing
      •  Nursing Homes
      •  Others
    • Market Analysis, Insights and Forecast By Geography
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa

Toc Continue…

Get your Customized Research Report:


  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.

Have a Look at Related Reports:

Heparin Market Size, Share & COVID-19 Impact Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source , By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration, By End User , and Regional Forecast, 2020-2027

Arthroscopy Fluid Management Disposables Market Size, Share & COVID-19 Impact Analysis, By Product (Pump Management Disposables and Gravity Management Disposables), By Application (Hospitals, Medical Centers, and Others) and Regional Forecast, 2020-2027

Liver Cancer Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Therapy Type (Targeted Drug Therapy, Immunotherapy, and Chemotherapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Immunomodulators Market Size, Share & COVID-19 Impact Analysis, By Product Type (Immunosuppressant, Immunostimulants), By Application (Oncology, Respiratory, Multiple Sclerosis, and Others), and Regional Forecast, 2020-2027

Medical X-ray Market Size, Share & Covid-19 Impact Analysis, By Product Type (Static and Dynamic), By Technology Type (Analog and Digital), By Application (Dental, Veterinary, Cardiovascular Oncology, and Others), By End-User (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, 2021-2028

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.